Discovery of a small-molecule inhibitor targeting the ovarian tumor domain of a novel Tamdy orthonairoviruse associated with human febrile illness

J Med Virol. 2022 Dec;94(12):5954-5964. doi: 10.1002/jmv.28089. Epub 2022 Sep 3.

Abstract

Tick-borne orthonairoviruses have been characterized as a global health threat to humans and animals. Tacheng Tick virus 1 (TcTV-1) from this family was provided as evidence that is associated with the febrile illness syndrome. Here, we first identify and demonstrate that the ovarian tumor (OTU) domain of TcTV-1 has remarkable deubiquitinating activity both in vitro and in vivo. By solving the crystal structure of TcTV-1 OTU (tcOTU) domain and comparing it to that of human deubiquitinating enzymes, we found that overall structures of tcOTU and human OTU family are similar, but the residues involved in the catalytic pocket vary widely. Based on the tcOTU domain we screened 5090 bioactive compounds and found mecobalamin had a good effect on suppressing the deubiquitinating activity. The structural model of tcOTU and mecobalamin suggests that mecobalamin occupies the site of the substrate Ub, by blocking the substrate binding to the enzyme. Thus, our results showed OTU domain of TcTV-1 has a robust deubiquitinating activity and mecobalamin or its derivatives might be promising candidates for the treatment or prevention of disease caused by the TcTV-1 virus.

Keywords: OTU domain; Tacheng Tick virus 1; deubiquitination; mecobalamin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Deubiquitinating Enzymes / metabolism
  • Female
  • Humans
  • Ovarian Neoplasms* / drug therapy
  • Ubiquitin* / metabolism

Substances

  • Ubiquitin
  • Deubiquitinating Enzymes